G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
about
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies.Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines.Characterisation of the potential function of SVA retrotransposons to modulate gene expression patternsNucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism.GC-elements controlling HRAS transcription form i-motif structures unfolded by heterogeneous ribonucleoprotein particle A1MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.G-ruption: the third international meeting on G-quadruplex and G-assembly.A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoterG-quadruplex structures in the human genome as novel therapeutic targets.Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer.HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.Genome-wide study predicts promoter-G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radiodurans involves G4 DNA-mediated regulation.A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro.Eicosapentaenoic acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells.Relevance of G-quadruplex structures to pharmacogenetics.An acetylene-bridged 6,8-purine dimer as a fluorescent switch-on probe for parallel G-quadruplexes.G-Quadruplex Supramolecular Assemblies in Photochemical Upconversion.Recent Advances in Nucleic Acid Targeting Probes and Supramolecular Constructs Based on Pyrene-Modified Oligonucleotides.Improved i-motif thermal stability by insertion of anthraquinone monomers.Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.Probing of G-Quadruplex Structures via Ligand-Sensitized Photochemical Reactions in U-Substituted DNAInterdependence of pyrene interactions and tetramolecular G4-DNA assembly
P2860
Q33615428-980BAED8-5BF3-4073-B1D1-58382295F5BFQ34194286-180E2B46-CB92-40EF-A5A8-7EEE47D74533Q34732755-487C09D6-FCC0-4911-B147-6F0F6EE11080Q36367297-113C7C50-4AF1-44CE-B0AB-D647CAB0549AQ36379638-ACD0B01C-8E07-4246-9742-80936E9BF527Q36769518-C1EA957F-D3FA-4C6D-A437-C0AC2A64947CQ36999908-E4B21681-BA67-4344-A459-6BE5DEFBCB2EQ37216613-71D77046-5B43-4A8B-B8C1-085DA3A02E0DQ38151013-E07FF18C-FA85-46B6-8D12-AE64294E3E2FQ38300047-E2FA324D-0932-483C-89C2-59374024780BQ38976432-F3CD7F75-6686-43C3-A863-3521590ACFE0Q41432433-47E04336-A961-44EE-AB55-1EC4298CD8B5Q41578212-E39E8BF9-22E6-4BE2-A34B-D10DB0BFEF90Q41869019-8F12C6ED-12C7-4F93-837D-37BA9C545753Q42065104-18CF8802-DEAE-4389-AC32-CA67E6F4AB6BQ43165574-513ACE9F-9278-4D4C-8343-E741F125E12BQ48042799-CA0C5350-E136-480B-89A5-4D8D6EA1ADF6Q48212408-65D89D3D-7E70-4F9B-8C10-DBF7D4DC4E3EQ53137923-561AE36E-6F3F-409E-97EA-7C01119E791DQ54204671-F06F6C85-0CE4-4324-8453-EF82F5E9EF40Q58563211-4BA0166B-E25C-42FE-912C-418CF135F6B6Q58621184-7B110705-0AEA-4A8E-817F-2399AD8F35B7
P2860
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@ast
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@en
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@nl
type
label
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@ast
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@en
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@nl
prefLabel
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@ast
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@en
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@nl
P2860
P1433
P1476
G4-DNA formation in the HRAS p ...... ucleotides for cancer therapy.
@en
P2093
Alexandro Membrino
Susanna Cogoi
P2860
P304
P356
10.1371/JOURNAL.PONE.0024421
P407
P577
2011-09-08T00:00:00Z